Clinical trials for autism drugs have been plagued with problems: bad design, the wrong measures, too broad a range of participants. All that is finally starting to change.
People with autism — and their family members — are susceptible to powerful placebo effects. Some researchers are using the problem to better understand this mystifying phenomenon.
A sweeping study of military health records reveals that children who take drugs to ease autism features are at risk for obesity-related conditions.
Depression is twice as common in women as it is in men, yet many do not receive the help they need, in part due to the stigma surrounding mental health issues.
A tie between first-trimester ultrasounds and autism severity is tenuous at best, misnamed genes litter the literature, and neuroscientists enjoy their version of summer camp.
A new blood test could personalize depression treatment, a journalist dissects the demise of a large children’s study, and the National Institutes of Health budget may grow by $2 billion.
Studies link taking antidepressants, acetaminophen and some asthma drugs during pregnancy to autism risk, but the dangers of going off them may outweigh the risks.
Prairie vole pups exposed to the antidepressant fluoxetine in the womb show autism-like behaviors and lose some receptors for oxytocin and vasopressin.
Spectrum Wiki is a community of researchers affiliated with an academic or research institutions. To be considered for participation, please fill out this form and a member of our team will respond to your request.